65O Phase III LEAP-008 study of lenvatinib plus pembrolizumab versus docetaxel for metastatic non-small cell lung cancer (NSCLC) that progressed on a PD-(L)1 inhibitor and platinum-containing chemotherapy

N. Leighl, L. Paz-Ares,D. Rodriguez Abreu, R. Hui,S. Baka, F. Bigot, M. Nishio,A. Smolin,S. Ahmed,A. Schoenfeld, S. Daher,D.L. Cortinovis,V.P. Di Noia,H. Linardou,J. Gainor, C.E. Okpara, X. Deng, D.A. Kush, A. Song,B.C. Cho

Immuno-Oncology and Technology(2023)

Cited 0|Views1
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined